Charts Suven Life Sciences Limited

Equities

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-29 EDT			5-day change	1st Jan Change
111.7 ^INR	+0.20%		+5.03%	+38.47%

04-15	Suven Life Sciences to Present Phase-2 Positive Results on Samelisant (SUVN-G3031) at American Academy of Neurology 2024 Annual Meeting, Denver, USA	CI
02-06	Suven Life Sciences Announces Randomization of First Patient in Phase-2 POC Clinical Trial of Ropanicant (SUVN-911) for the Treatment of Moderate to Severe Major Depressive Disorder Study in USA	CI

ProRealTime Chart